Skip to main content
main-content

25.07.2017 | Original Research Article | Ausgabe 2/2017

Documenta Ophthalmologica 2/2017

Safety of intravitreal clindamycin in albino rabbit eyes

Zeitschrift:
Documenta Ophthalmologica > Ausgabe 2/2017
Autoren:
Zohar Habot-Wilner, Orit Mazza, Jonathan Shahar, Amir Massarweh, Irit Mann, Anat Loewenstein, Ido Perlman
Wichtige Hinweise
Zohar Habot-Wilner and Orit Mazza have contributed equally as first authors.

Abstract

Purpose

To study the potential toxic effects of intravitreal clindamycin on the retina of albino rabbits, by assessing functional and morphological retinal changes.

Methods

Eight albino rabbits were included in the study. In each rabbit, 1 mg/0.1 ml clindamycin was injected into the vitreous of the right (experimental) eye, and 0.1 ml saline was injected into the vitreous of the left (control) eye. The electroretinogram (ERG) was recorded before injection, 3 days, 1, 2, and 4 weeks post-injection. The visual evoked potential (VEP) was recorded 4 weeks post-injection. Clinical examination was conducted at all time points. The eyes were enucleated at the termination of the follow-up period in order to prepare the retinas for histology in order to assess retinal structure.

Results

ERG and VEP responses that were recorded from the experimental eye at different times following intravitreal clindamycin injection were very similar to the corresponding responses that were recorded from the control eyes. Clinical examination was normal in all eyes, and no histological damage was observed.

Conclusions

Intravitreal injection of 1 mg clindamycin does not cause functional or morphological signs of retinal toxicity in albino rabbits, during a period of 4 weeks post-injection. These findings support the clinical use of 1 mg intravitreal clindamycin.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Nicht verpassen: e.Med bis 13. März 2019 100€ günstiger im ersten Jahr!

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 2/2017

Documenta Ophthalmologica 2/2017 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde